Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Fujirebio Diagnostics AB
AB
Active
Org 5564504966
Gemenskapens Gata 7, 431 53
Mölndal
Manufacture of other chemical products n.e.c.
· NACE 2059
Est. 1992
83 employees
Watchlist
Share
Sweden
/
Companies
/
Manufacture of other chemical products n.e.c.
/
Fujirebio Diagnostics AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
89M
178M
267M
357M
241M
2021
252M
2022
300M
2023
310M
2024
306M
2025
EBITDA
SEK millions
0M
47M
94M
141M
187M
131M
2021
130M
2022
163M
2023
149M
2024
135M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
241 195
252 059
299 954
309 960
306 431
Staff expenses
—
—
—
—
—
EBITDA
131 379
130 486
163 425
148 908
135 277
Depreciation & amort.
—
—
—
—
—
EBIT
131 379
130 486
163 425
148 908
135 277
Net financials
−29 270
2 314
11 032
18 355
−5 697
Profit before tax
100 009
128 700
171 557
164 113
142 161
Tax
−21 420
−26 550
−34 724
−33 848
−24 186
Net profit
78 589
102 150
136 833
130 265
117 975
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
447 667
588 268
620 373
767 349
708 341
Equity
402 060
504 210
541 042
596 308
564 282
Long-term debt
0
0
0
0
0
Short-term debt
20 857
55 208
47 581
137 591
109 009
Total debt
20 857
55 208
47 581
137 591
109 009
Financial ratios
5-year trend
EBITDA margin
44.1%
This company
15.8%
Market median
+179% vs market
2021
2025
Equity ratio
79.7%
This company
38.2%
Market median
+109% vs market
2021
2025
Return on equity
20.9%
This company
18.4%
Market median
+14% vs market
2021
2025
Net profit margin
38.5%
This company
8.1%
Market median
+375% vs market
2021
2025
Asset turnover
0.43×
This company
1.12×
Market median
-62% vs market
2021
2025
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
View
PDF
More on Fujirebio Diagnostics AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
